Web-based info may not increase cancer screening

Key points
- Offering women information on colon cancer screening via the web does not get them to take up screening any more effectively than printed materials, according to a new study.
- "It's disappointing that the web didn't have more effect," said Dr.
- Preventive Services Task Force recommends that adults between ages 50 and 75 get screened regularly for colorectal cancer, about 40 percent of people don't follow those guidelines.
- To raise awareness of the recommendations and encourage people to go get screened, researchers have developed a variety of approaches, Weinberg said, including videos and printed materials.
Offering women information on colon cancer screening via the web does not get them to take up screening any more effectively than printed materials, according to a new study.
"It's disappointing that the web didn't have more effect," said Dr. David Weinberg of Fox Chase Cancer Center in Philadelphia, the report's lead author.
Although the U.S. Preventive Services Task Force recommends that adults between ages 50 and 75 get screened regularly for colorectal cancer, about 40 percent of people don't follow those guidelines.
To raise awareness of the recommendations and encourage people to go get screened, researchers have developed a variety of approaches, Weinberg said, including videos and printed materials. But none of these "have been tremendously successful," he added.
Dr. Hamant Roy, director of gastroenterology research at NorthShore University HealthSystem in Evanston, Illinois, said one method that has been shown to be effective is simply having doctors spend time with their patients to talk about the cancer tests.
"But one of the issues is they have to see more and more people with less and less time, so it gets really hard to have these discussions with patients," said Roy, who was not involved in the new study.
To see whether the web might provide an easily accessible and inexpensive alternative for getting people to comply with screening recommendations, Weinberg and his colleagues asked 865 women who were coming in for routine gynecology appointments to participate in the study.
Of those, 171 saw their doctor as normal, 349 also received printed materials about colon cancer screening at the time of their visit and 345 were offered access to a web site that contained the same information as the printed matter.
Included in the materials was information about the benefits of screening and harms of going unscreened, as well as background on the various types of colon cancer screen available: a stool test once a year, a sigmoidoscopy every five years or a colonoscopy every 10 years.
All the women were eligible to get screened for colon cancer based on their age and health status.
Four months after the doctor visit, however, roughly 12 percent of the women - regardless of whether they received the extra information or not - had gotten a colon cancer screen.
Roy called the numbers "dismal."
"At the end of the day, something is better than nothing," he said, but compared to screening rates for breast cancer, the uptake for colorectal cancer screening was quite low.
Among the women in the study, published in the Archives of Internal Medicine, 73 percent had received a mammogram in the past year.
On the other hand, Weinberg said, "you might argue their participation in the study did manage to raise their interest level enough" to get screened.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsACP releases advice for the proper time, test, and interval for cervical cancer screening
The American College of Physicians (ACP) today released clinical advice aimed at reducing overuse of cervical cancer screening in average risk women without symptoms. "Cervical Cancer Screening in Average Risk Women" is…
1 May 2015
NewsToxic mushroom-based drug may help battle colorectal cancer
For some time, cancer scientists have considered the toxin, alpha-amanatin derived from "death cap" mushrooms, as a possible cancer treatment. However, due to its penchant for causing liver toxicity, its potential as an…
23 April 2015
NewsMRI screening program for individuals at high risk of pancreatic cancer
A magnetic resonance imaging (MRI)-based screening program for individuals at high risk of pancreatic cancer identified pancreatic lesions in 16 of 40 (40 percent) of patients, of whom 5 five underwent surgery,…







